Previous 10 | Next 10 |
Introduction I have held AbbVie ( ABBV ) since it was originally spun off from Abbott Labs. Moreover, I have been aggressively adding to my position for clients needing current income and dividend growth. All in all, it has been an excellent performer in spite of the fact that it is being ri...
AbbVie Inc. (ABBV) has reached a deal with Allergan (AGN) for about $188 per share in cash and stock. Allergan shareholders get $120 in cash and 17% of the combined company (the value of that is in flux, so take the numbers with a grain of salt). This implies there is still a very widespread o...
The biopharma sector has turned into some of the deepest value stocks in the market. The Allergan ( AGN ) acquisition by AbbVie ( ABBV ) is a prime example of a deal where the involved stocks trade at insanely cheap valuations causing the merger synergies to provide a big boost to the EP...
Gainers: Pyxus International (NYSE: PYX ) +28% . Allergan (NYSE: AGN ) +26% . ENDRA Life Sciences (NASDAQ: NDRA ) +23% . Pier 1 Imports (NYSE: PIR ) +18% . Rafael Holdings (NYSEMKT: RFL ) +16% . Riot Blockchain (NASDAQ: RIOT ) +15% . Vislink Technologies (NASDAQ: VISL ) +15% ....
NEW YORK, June 25, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Allergan plc (NYSE: AGN) to AbbVie Inc. (“AbbVie”) is fair to Allergan shareholders. On behalf of Allergan shareholders, Halper Sadeh LLP may s...
Mergers is the sign of a healthy stock market AbbVie (ABBV) is buying the long-suffering Allergan (AGN) for 63 billion bucks. Long-term readers might remember me making a strong case to go long on AGN because of the charts, and then Carl Icahn got involved, so we were able to escape with som...
The following slide deck was published by AbbVie Inc. in conjunction with this Read more ...
Allergan plc (NYSE: AGN ) +31% as AbbVie is in the final stages of a $188/share bid . More news on: Allergan plc, Phunware, Inc., Pyxus International, Inc., Stocks on the move, Read more ...
NORTH CHICAGO , Ill. and DUBLIN , June 25, 2019 /PRNewswire/ -- AbbVie Inc. (NYSE: ABBV) and Allergan plc (NYSE: AGN) announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction...
DUBLIN , June 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced CoolTone device received FDA clearance for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen. CoolTone is also indicated for strengthening, toning and fi...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...